Explore every episode of the podcast The ONS Podcast
| Title | Pub. Date | Duration | |
|---|---|---|---|
| Episode 327: Journey of a Student Nurse: Choosing Oncology Nursing and the Value of a Professional Home | 30 Aug 2024 | 00:55:11 | |
"It's not often in life that you find something that gives you this feeling, but I'm really so fortunate to have found mine, and I know this is only just the beginning, and I cannot wait to see what the future holds. I definitely owe a lot of that to the Oncology Nursing Society for opening up all those doors for me and really getting me into this field." Samantha Paulen, BSN, RN, told Jessica MacIntyre, DNP, MBA, APRN, AOCNP®, 2024–2026 ONS president, during a conversation about student nurses entering the oncology field. MacIntyre spoke with Paulen and Tayler Covino, BSN, RN, both recent graduate nurses, about why they chose oncology nursing as a specialty. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Episode Notes
To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an Oncology Nursing PodcastÔ Club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "I was first drawn to oncology nursing freshman year of high school when my grandmother, who was my ultimate best friend, was diagnosed with pancreatic cancer, and by the time they had caught it, it had metastasized to nearly every surrounding organ. And as I mentioned earlier, my grandmother was a nurse. So being a nurse, she was very stubborn, and when she finally had gone to the hospital after having a variety of symptoms, it was almost too late." (Paulen) TS 7:27 "There's really nothing more special to me than being able to develop relationships with my patients and support them throughout their journey. It's incredibly rewarding making such a difference in their lives and being able to witness the strength and resilience of patients battling cancer, and it's such an inspiration. Being able to provide my support both medically and empathetically is truly such an honor." (Paulen) TS 10:04 "I also had a family member who was diagnosed with cancer. He was my uncle. And I witnessed firsthand the impact that compassionate and knowledgeable oncology nurses had on his treatment, and it really did leave such a lasting impact on me. … This experience deeply inspired me, and I just always wanted to be part of a team that offers hope and comfort to their patients and their families." (Covino) TS 12:10 "I touched on my pediatric oncology clinical rotation, but I really do think it gave me insights into caring for younger cancer patients. This experience really emphasized the importance of a holistic approach to nursing, considering not just medical but also the emotional and developmental needs of children who are battling cancer." (Covino) TS 24:05 "I also joined ONS as a student, so it was a large part of my college education and really gave me great access to resources, being able to attend meetings, and just stay updated on the latest in oncology nursing with the articles that they send out and just provided me with great networking opportunities with so many experienced oncology nurses who have such a wide breadth of knowledge." (Covino) TS 24:27 "Practicing mindfulness and meditation has also been incredibly helpful in staying grounded and managing the emotional stress. These practices help me stay present. They reduce anxiety and maintain a positive outlook, even in these challenging environments. It's really important to just set emotional boundaries as well to avoid burnout." (Covino) TS 33:05 "There's such a fulfillment that you get for making a significant impact on patients' lives, and that's what inspires me and should inspire others to consider this specialty. There's also a lot of growth opportunities, and I think it's really important to emphasize the growth opportunities within the field. And also just the advancements in cancer treatment can attract new nurses because there really is so much advancement in the field of cancer treatment." (Paulen) TS 42:59 "I feel that specifically in this specialty, oncology nurses in particular are so much more willing to help versus they say that sometimes some nurses may eat their prey or whatever they might say. But I really think that oncology nurses are so willing to help, but sometimes you just have to really expose yourself and open up that door." (Paulen) TS 45:07 | |||
| Episode 326: Intramuscular Injections: The Oncology Nurse's Role | 23 Aug 2024 | 00:29:39 | |
"One of the big misconceptions is that this is just a quick shot. And this is a patient's treatment regimen. So, it is not just a quick shot. It is treatment, and we need to get it where it is supposed to go so that the patient's, cancer treatment is not impacted," Caroline Clark, MSN, APRN, OCN®, AG-CNS, EBP-C, director of evidence-based practice and inquiry at ONS, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about administering intramuscular (IM) injections in oncology. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by August 23, 2025. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to the administration of antineoplastic medications by IM injection. Episode Notes
To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an Oncology Nursing Podcast Club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "More frequently oncology nurses are using intramuscular injection techniques when giving certain hormonal therapies for cancer treatment and for cancer symptom management. Some examples of those are fulvestrant for treatment of hormone receptor–positive, HER2-negative breast cancer, leuprolide as androgen deprivation therapy in prostate cancer. This is also used off label for breast cancer management. It's used for premenopausal ovarian suppression and also in noncancerous conditions like endometriosis and uterine fibroids." TS 2:04 "Inadvertent injection into the sciatic nerve is one of the most common causes of sciatic injury. It has significant morbidity associated with it. And even for drugs like fulvestrant, the prescribing information notes reports of sciatica, neuropathic pain, neuralgia, peripheral neuropathy—all related to dorsogluteal injection." TS 6:09 "When administering an IM injection to someone who is cachectic, you don't want the subcutaneous tissue to bunch up. So you can kind of stretch this over with your nondominant hand, as in the Z-track method, and then grasp the muscle between your thumb and index finger. That's going to help you ensure that you're getting that muscular injection." TS 11:47 "Z-track is a way that you inject so that there's no leakage back out into the subcutaneous space. Clean your area as usual. You displace the skin and the subcutaneous tissue that's over that muscle, and then you inject slowly into the muscle. Once you remove the needle, then you release that tissue. And it kind of seals it over and prevents that leakage back up into the subcutaneous space." TS 14:19 "I think ventrogluteal injection is less commonly done. There are documented issues with confidence in landmarking and giving it to that site, so practice is necessary. A great way to identify the ventrogluteal site on yourself to start is to stand up and put your hand at your side. You feel for the top of that iliac crest. Place your hand right below the iliac crest and then just start marching in place. You're going to feel that muscle contraction right away. This also works when you abduct your leg. Abducting the leg is helpful when a patient is at a side-lying position to give a ventrogluteal injection—you feel that muscle contraction." TS 17:06 "I wish it would be front of mind to encourage adverse event reporting related to any injection you're giving. These types of reports—they drive improvement measures and monitoring. And then when things are underreported, it leads us to anecdotal reports. So really monitoring any change, trying to get some baseline data on adverse events with injection is really important." TS 26:32 | |||
| Episode 317: AYAs With Cancer: A Patient's Experience | 21 Jun 2024 | 00:47:21 | |
"I was in this really unique space of being 19. So I'm over the 18 cut-off of peds but diagnosed with Ewing sarcoma, but I was an adult. I was able and supposed to be making my own decisions but treated in a pediatric setting. And not everybody in that setting is expecting to talk to someone who is educated and understands what's going on," Alec Kupelian, a cancer survivor and operations and program development specialist at Teen Cancer America in Los Angeles, CA, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about advocacy for adolescents and young adults (AYAs) with cancer and his own cancer journey. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to the experience of AYA patients with cancer. Episode Notes
To find resources for creating an ONS Podcast Club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "I joke a lot of the times that cancer was actually one of the best years of my life, and that's not because it was good necessarily. It's because that next year, after cancer, was probably the worst year of my life, and that drop-off into that early survivorship was a really brutal experience for me, and from talking to other cancer survivors, for them as well." TS 3:25 "I talk to a lot of clinicians and a lot of young adult cancer survivors, and the more that I hear other people's stories, the more clear it is to me that you never know who a patient is going to disclose information to. A lot of those symptoms or side effects or secondary issues that come about from cancer, which complicate every part of your life, it may not come to the [physician]. I was most comfortable with my nurses because I spent time with them." TS 9:15 "You put your nose to the grindstone, and there's a good guy, which is you, and a bad guy, which is cancer, and you just get through it. It's very clear. And you have so much attention and dedicated support. And then when treatment's over, everybody pats your back, dusts their shoulders, and says, 'Congrats, go get out there.' And all that structure goes away, and you are left floundering, trying to reconnect to what you were before and what life looked like. And it's not always the same. … Most AYA patients would say treatment was the easy part. And those first two years after treatment were the hardest part of cancer—that reintegrating into life, that trying to contend with what just happened when you're no longer in survival mode." TS 26:14 "An AYA patient may have another 50 years of life after that. How does survivorship work for that? What is sexual health? Fertility? What is palliative care? … What does end-of-life care look for a patient who hasn't gotten a chance to live their whole life? It's really important stuff, and that is too much to ask any one person to figure out. And so Teen Cancer America wants to provide some of that framework." TS 31:03 "Allowing nurses to say that, 'There is going to be stuff that I don't know, and that isn't a failing on my part. Saying I don't know something helps my patient have more confidence in me.' I hear all the time clinicians are like, 'I don't bring up sexual health because I don't know what to say, and I don't want them to lose confidence in me.' They don't. They don't lose confidence in you because you don't know something. You're a human, also. They lose confidence in you when you stop caring about them." TS 43:44 | |||
| Episode 227: Biomarker Testing, PARP Inhibitors, and Oral Adherence During Ovarian Cancer Maintenance Therapy | 30 Sep 2022 | 00:43:36 | |
"We found that nurses still needed clarity of terminology and the rationale for germline, somatic, and homologous recombination deficiency testing," ONS member Paula Anastasia, MN, RN, AOCN®, clinical nurse specialist for UCLA Health in Los Angeles, CA, told Jaime Weimer, MSN, RN, AGCNS-BC, AOCNS®, oncology clinical specialist at ONS. Anastasia discussed the findings of a July 2022 ONS focus group that she facilitated on PARP inhibitor therapy, biomarker testing and terminology, and oral medication adherence for patients with ovarian cancer. This podcast episode is supported by a sponsorship from AstraZeneca. ONS is solely responsible for the criteria, objectives, content, quality, and scientific integrity of its programs and publications. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Episode Notes
To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From Today's Episode "We found in this focus group that nurses still needed clarity of terminology and the rationale for germline and somatic/homologous recombination deficiency (HRD) testing. They all shared that those who worked in the infusion center in general medical oncology offices as opposed to the specific gynecologic clinics, that they weren't as familiar with somatic and HRD terminology as you would suspect." Timestamp (TS) 06:31 "As cancer care is evolving and patients are living longer and better, I think it's we nurses who are actually the ones that are doing these behind the scenes. The most common barriers that were consistently discussed across the board were cost and insurance approvals. . . . Other issues were access to the results. Results are not always being uploaded into the patient's medical record." TS 09:51 "The nurses discussed wanting more knowledge of the mechanism of action with PARP inhibitors and how that alteration benefits patients with germline or somatic mutations. And most nurses did agree that their patients were offered germline testing at the time of diagnosis, but they were unclear as to when somatic or HRD testing was being done. . . . It was very inconsistent, so not all nurses knew where to find these results or to even know if it was done." TS 16:54 "Education was key, and the nurses all agreed that it was important to identify who the appropriate patient would be that would most likely receive a clinical benefit, and who also would be following through or maintaining oral adherence. It was recommended to reinforce the side effects with the patients. . . . It was determined that patients should be informed that the goal of treatment of maintenance therapy was to prevent or decrease risk of recurrence." TS 18:17 "It was recommended to assess patient adherence by asking open-ended questions. . . . The nurses agreed that the most common question to ask a patient would be: 'How many doses did you miss this week? Or this month?' Recognizing that people miss doses, and it's not necessarily intentional, but it does happen, so we are validating and giving them permission to be honest with us." TS 21:26 "I think having tools or resources—quick handouts—that they can give their patients that's like an easy guide, and they can review it with the patient, but the patient if they have questions can follow up. I think it's important to find out the patient's needs and how they learn best, on a video or paper, that sort of thing. . . . But the nurses also wanted quick-references guides, just an overview of what the indication is, what needs to be done prior to ordering this, and the mechanism of action." TS 30:32 | |||
| Episode 226: Patient Education for Next-Generation Sequencing to Guide Cancer Therapy | 23 Sep 2022 | 00:47:01 | |
"Nurses can bridge the information gap and help patients better understand that the information received from next-generation sequencing (NGS) can really help to determine which treatment they will respond best to, if there are therapies that won't be effective, or if there are clinical trials that are open to them based on the results," Danielle Fournier, RN, MSN, APRN, AGPCNP-BC, AOCNP®, CORLN, advanced practice RN in the department of thoracic surgery at MD Anderson Cancer Center in Houston, TX, told Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS. Fournier discussed the advancements being made in NGS technology and how it can be used to care for patients with cancer. This episode was produced by ONS and sponsored by Foundation Medicine. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Episode Notes
To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From Today's Episode "With next-generation sequencing (NGS), multiple biomarkers can be evaluated using one test. So, in cancer care, we're learning that any given tumor may harbor a variety of variants. So, if we're considering using in situ hybridization (ISH) or fluorescence in situ hybridization (FISH) to identify biomarkers, multiple assays may be needed and may need to be performed in order to test for multiple variants." Timestamp (TS) 10:21 "There are multiple testing strategies that can be used with NGS technology, which is kind of what makes it so versatile. What type of testing is most appropriate really depends on the patient's risk factors, their diagnosis, their cancer stage, what testing has previously been completed, and what tissue is available for analysis." TS 12:00 "Within oncology care, there is a role for NGS in the identification and management of both solid tumors and hematologic cancers, and this role is likely just going to continue to expand. So, really there's been an increased focus on genomic pharmacotherapy and targeted therapy, and this is playing an ever-greater role in the treatment of cancer. So, NGS will really continue to serve as a means to take a closer look at a patient's cancer at the molecular level and hopefully match patients with treatments that will be most effective at treating their cancer." TS 20:54 "In reality, there's an expanding role for NGS testing in the diagnosis of many complex diseases. So, I think more than likely what we're going to see is that the indications and utility of NGS is only going to continue to grow in both the oncology setting as well as the non-oncology setting." TS 23:08 "The oncology nurse really plays a key role in several important steps along the way. The first place they may be involved is in the informed consent process. Many—but not all—hospitals require patients to sign consent for genetic and genomic testing and this is just acknowledging that the patient is making an informed and autonomous decision related to their health care. Nurses may also play a role in the collection of a tissue sample or blood sample. And once testing has been completed, nurses may play a role in discussing the NGS results with patients." TS 24:03 "Nurses really can help to somewhat bridge this information gap and help patients better understand that the information received from NGS can really help to determine which treatment they will respond best to, if there are therapies that won't be effective, or if there are clinical trials that are open to them based on the results. And these are all really important considerations for cancer treatment." TS 36:21 | |||
| Episode 225: Central Line Dressing Changes: Get It Right the First Time | 16 Sep 2022 | 00:34:08 | |
"Really knowing these steps can save our own nursing time and save our patient's skin from all the dressing removals. If we're not doing these dressings as much, we're all going to be happier," MiKaela Olsen, DNP, APRN-CNS, AOCNS®, FAAN, clinical program director in oncology at the Johns Hopkins Hospital and Johns Hopkins Health System in Baltimore, MD, told Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, during a discussion on the importance of properly changing central line dressings and recommendations in practice. You can earn free NCPD contact hours after listening to this episode by completing the evaluation linked below. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Episode Notes
To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From Today's Episode "One of the most important points at which a line can become infected is at the insertion site. So that central line dressing is of the utmost importance. We cannot ignore it and we have to inspect it frequently and teach our patients to do the same so that they don't have an infection caused by bacteria getting into that insertion site." Timestamp (TS) 04:28 "If we don't get the dressing right and we don't do a good job with it, it's not going to be clean, dry, and intact. It's going to come off too soon. We really want our transparent, highly moisture-permeable dressings that we put over our central line catheters to stay on and meet the guidelines to stay on for seven days, and then we need to do a dressing change. If they come off sooner and you're having to change them more frequently, then that can increase the risk of central line–associated bloodstream infections." TS 12:07 "It's really important that when you are doing these dressings, you have a very simple procedure in place to validate skill for the staff, and they do the same steps every time. But it's very important that they do all the steps and that they always make sure that they have good dry time in between every step." TS 13:10 "Bleeding is definitely a challenge, and sometimes it's related to the way the line was inserted, if they used a cutting mechanism at the site instead of using a dilation. Sometimes the root of the problem can be that you have to go back to the people who inserted the catheters and tell them about the downstream effects and tell them some of the techniques." TS 20:05 "If you stack dressings on top of your transparent dressing, it can no longer breathe. And now, it is going to trap moisture under there and cause infection. How you apply each of these chemicals, the dry time—there is definitely a science behind doing a dressing change. So really knowing these steps can save our own nursing time and save our patient's skin from all the dressing removals. If we're not doing these dressings as much, we're all going to be happier." TS 29:37 | |||
| Episode 224: Meet the ONS Board of Directors: Nevidjon, Geddie, and Garner | 09 Sep 2022 | 00:27:35 | |
What is it like to guide a professional association that serves more than 100,000 oncology nurses? ONS Chief Executive Officer Brenda Nevidjon, MSN, RN, FAAN, and Directors-at-Large Patricia (Patty) Geddie, PhD, APRN, AOCNS®, FCNS, and Danya Garner, PhD, RN, NPD-BC, OCN®, CCRN-K, reflect on their experiences with ONS, how a diverse Board supports a diverse membership, and how you can get involved in ONS leadership. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation. Episode Notes Check out these resources from today's episode:
To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From Today's Episode Garner: "Obtaining a PhD in nursing has always been a goal since I entered my initial program, because I've had the goal to always teach and give back to nurses. I am the first person in my family to obtain a PhD and was encouraged by my family to acquire more education. They didn't necessarily say, 'You need to get a PhD,' but rather, 'Get the education you need to fulfill your life goals,' and I've really seeded that throughout my lifetime." Timestamp (TS) 06:30 Geddie: "Sometimes it is difficult to receive honest feedback, but it is much appreciated. . . . When honest feedback is given from a sincere and authentic perspective, you grow and develop so much from it." TS 09:42 Nevidjon: "As board members, you also give feedback to one another. That is part of the board experience. When a new board member comes on, there is a 'board buddy' who is assigned, and then there are check-ins in terms of how things are going, what kinds of experiences [there are]. We embrace that in terms of the board experience." TS 10:03 Garner: "Mentorship is a great opportunity for growth and self-reflection. I believe that mentorship is a continual journey. There is so much to learn from others as well as impart what you have learned to others." TS 10:53 Nevidjon: "The path to a national board isn't necessarily just within that organization itself, but the total kind of experiences that you bring." TS 14:07 Geddie: "When I began my oncology nursing career, I could always identify gaps where improvement was needed to enhance the daily practice of nurses in the acute care setting. I could not make a difference to improve practice while providing direct care every day, so I decided to pursue a master's degree for the clinical nurse specialist. And this role allowed me not only to stay close to clinical practice but to also drive improvements in the healthcare system in which we worked." TS 18:14 | |||
| Episode 223: Oncologic Emergencies 101: Superior Vena Cava Syndrome | 02 Sep 2022 | 00:25:50 | |
"I think that we as nurses need to advocate when a patient is uncomfortable. And it's not your classic 'pain in my hip' kind of thing. This is a more subtle, 'I can't breathe, I have a sense of impending doom, I'm panicked, I want someone beside me.' It may sometimes appear to be a psychosocial coping issue when it really is a physiologic one," ONS member Brenda Shelton, DNP, RN, AOCN®, clinical nurse specialist at Johns Hopkins Medicine in Baltimore, MD, told Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS. Shelton discussed the warning signs of superior vena cava syndrome and nursing considerations for its management. This episode is part of a series about oncologic emergencies; the others are linked in the episode notes. You can earn free NCPD contact hours after listening to this episode by completing the evaluation linked below. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation. Episode Notes
To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From Today's Episode "Superior vena cava syndrome was first recognized with tuberculosis, and now it's almost exclusively going to occur in patients with cancer because it's physiologically the outcome of too much mass in between the sternum and the spine." Timestamp (TS) 01:57 "You might see some very subtle right arm heaviness, edema; you might see a prominent right antecubital, or prominent veins on the hand of the right arm, or a prominent right jugular vein. But these are all things that can be subtle, and the patient may present with aching of the arm, numbness or tingling of that arm, just really things that don't necessarily raise your awareness because it's not the classic signs or symptoms you see in your textbooks." TS 05:35 "When we think of superior vena cava syndrome, we associate it with upper body edema, particularly worse in the morning when somebody rises after having laid flat for all night. . . . But the thing that patients report the most is dyspnea. It is not necessarily entirely due to respiratory problems. In this case, it's due to compression of the vena cava and an alteration of the blood returned to the heart that leads to an altered cardiac output." TS 06:45 "The three biggest life-threatening complications I think about are airway incompetence, cardiovascular collapse, and clotting. As you compress the vena cava, you are going to diminish the blood return into the heart, and this is going to compromise your ability to oxygenate that blood and put it back out the other side." TS 08:46 "We always start with a total body assessment, and it's hard because this patient is going to present with potentially neurologic symptoms, cardiac and respiratory symptoms, as well as just generalized discomfort and constitutional symptoms. You know, we're so focused sometimes on febrile neutropenia and the very classic complications, that this one is a little more subtle. And so the nurse needs to be very comfortable with their cardiovascular assessment in general and be looking at vessels and be looking at jugular venous distention and pulsations." TS 15:32 "I think that we as nurses need to advocate when a patient is uncomfortable. And it's not your classic 'pain in my hip' kind of thing. This is a more subtle, 'I can't breathe, I have a sense of impending doom, I'm panicked, I want someone beside me.' It may sometimes appear to be a psychosocial coping issue when it really is a physiologic one." TS 17:16 "We often think of this as something that is a sign of terrible, bad, irreversible disease, when in fact, it could be the presenting symptoms." TS 19:32 | |||
| Episode 222: Ethical and Moral Dilemmas of Futility in Cancer Care and Treatment | 26 Aug 2022 | 00:41:51 | |
"Let's take time, invest time, in learning more about futility. Let's invest some time in learning more about how to understand our patient's goals, their family's goals, what their values are," Kathleen Turner, BSN, RN, CHPN, CCRN-CMC, clinical nurse in the medical-surgical intensive care unit at the University of California, San Francisco, Medical Center, told Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, during a discussion on a nurse's approach to futility in cancer care and treatment. You can earn free NCPD contact hours after listening to this episode by completing the evaluation linked below. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation. Episode Notes
To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From Today's Episode "Medical futility has traditionally been framed as care that can't achieve its stated purpose. For instance, treating myocardial infarction with an antibiotic. There's no way that that medicine is going to fix somebody's heart attack. Often, though, I think it is something that we tend to invoke in our own practice when we feel like the care that we're providing may not be able to achieve our goal for the patient—and I mean our personal goal as opposed to a clinical goal. And from there, moral distress arises." Timestamp (TS) 02:40 "I think that there's a tremendous opportunity for nurses to also actively participate in that conversation, especially oncology nurses, because we are with patients throughout their continuum of care and work with people for a long time and have more 'in-the-room-time' with our patients. I think of the nurses who had been giving my own mom her chemotherapy, where they spend so much time in the room with her and talking about her impressions of her care, what she wants, what's important, what's a meaningful result, and we can share that with our physician colleagues." TS 04:38 "I think it's the question of, 'Because there is another thing that we can do, should we do it?' That feeling of futility that clenches at our heart, at our guts, that's a signal to us to stop and think, 'What is the goal of treatment? Whose goal is that? And is what's happening right now aligned with that goal, or have we somehow gone astray?'" TS 08:51 "When futility rears its head in our nursing practice, our first duty to ourselves and our patients is to take a pause. . . . Stop and reflect with a learner mindset on, 'What it is I'm not seeing in this situation, whose voice is not being heard, what are my assumptions and biases?' And then think about, 'What's another narrative that I can write about this situation?,' trying to be very mindful of other patients that we've cared for in similar situations where we might be bringing or protecting these other patients onto this current patient." TS 09:40 "Several years ago, when I was really going through some struggles in the ICU with this issue of futile or potentially inappropriate care, I went to a workshop and learned this mnemonic called GRACE to help clinicians remain compassionate and see what is the ethically appropriate thing to do in really fraught situations." TS 16:18 "Let's take time, invest time, in learning more about what is futility. Let's invest some time in learning more about how to understand our patient's goals, their family's goals, what their values are. Taking some time to invest in communication training, ethics—if clinical ethics is something that's a particular interest to you—that's a great way to start, but also just really investing in learning how to communicate." TS 36:18 | |||
| Episode 221: Surgical Interventions for Patients With Cancer | 19 Aug 2022 | 00:43:08 | |
"Our goal in surgical oncology is, of course, to treat the cancer for a cure, but to do it in a safe manner so the patient is able to recover and resume their normal living activities that they had before their surgery," ONS member Lisa Parks, MS, APRN-CNP, ANP-BC, inpatient nurse practitioner of hepatobiliary surgery at the James Cancer Hospital and Solove Research Institute, Division of Surgical Oncology, at the Ohio State University Wexner Medical Center in Columbus, OH, told Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, during a discussion on prehabilitation and preoperative assessments for patients with cancer undergoing surgery, implications of and advancements in cancer surgery, and the interprofessional collaboration that takes place in this scenario. You can earn free NCPD contact hours after listening to this episode by completing the evaluation linked below. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 0.75 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at myoutcomes.ons.org by August 19, 2024. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation. Episode Notes
To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From Today's Episode "Prehabilitation for surgery is probably one of the most underutilized areas of the surgical process. The goal of prehabilitation is to initiate coordinated, preoperative, optimized strategies. During the patient's preoperative assessment by the oncology nurse in the clinic, as well as the provider, risk factors are identified that can be addressed for a better surgical outcome." Timestamp (TS) 02:27 "Any solid tumor patient that is having an oncological surgery can benefit from prehabilitation. It really depends on their overall assessment preoperatively. . . . And certainly, any lengthy surgery that is going to require the patient to be under anesthesia for prolonged time, the patient would benefit from being optimized prior to a surgical procedure." TS 07:43 "When a patient is initially seen by a surgical oncologist in a pre-op setting, all of these assessments are completed by the oncology nurse, as well as the advanced practice oncology nurse, for the patient. And in order for the patient to go through the surgical process, prehabilitation is started immediately after that initial visit. The patient will be brought back in and reassessed periodically while going through prehabilitation." TS 09:03 "Our goal in surgical oncology is, of course, to treat the cancer for a cure, but to do it in a safe manner that the patient is able to recover and resume their normal activities that they've been living, that they had before their surgery." TS 10:51 "I think [one] of the greatest challenges that I hear from nurses are family support. The family needs to understand the whole process of prehabilitation and the fact that the patient is not going to come to harm by waiting a couple weeks to optimize themselves to undergo a major cancer operation, and to make sure that they're providing transportation and assisting their family member if they need to go to outpatient physical therapy, occupational therapy, pulmonary rehab, things like that, that the provider may, based on assessment, refer these preoperative candidates for." TS 12:18 "I think that people always think of surgery as being curative, but a lot of times, some of the procedures that we do are to sustain a quality of life for the patient at the end of their life." TS 20:41 "Now, what I'm seeing is that the majority of the time, robotic surgery is utilized more often than an open surgery. Of course, any time there is uncontrolled bleeding, any time they're unable to really visualize the surgical field well, they may start out robotically, and then go to an open procedure, but certainly I'm seeing them starting the cases and scheduling them as robotic or robotic-assisted. . . . I just think that robotic-assisted surgery continues to really grow, and I don't think we've reached the full potential of what surgeons can do with the surgeries. There is a great learning curve for these surgical oncologists." TS 28:10 "Surgical oncology nurses are trained in post-operative care, preoperative care, and for nurses that are in the OR, perioperative nursing, as well as oncology. They have to be competent, not only in surgical care, but in oncology care, too. . . . This specialty is very different than a medical oncology nurse, or a hematology nurse, who is mainly giving chemotherapies, CAR T's, immunotherapies. The surgical oncology nurse needs to understand what chemotherapies, treatments, radiation therapies, anything like that, that has been done with that patient, because that would certainly impact that patient's outcome, but also to understand the whole surgical process." TS 31:28 | |||
| Episode 220: Oncologic Emergencies 101: Febrile Neutropenia and Sepsis | 12 Aug 2022 | 00:33:14 | |
"It's actually the nurse who most often first identifies the subtle signs of sepsis in patients. Trust your clinical judgement," ONS member Laura Zitella, MS, RN, ACNP-BC, AOCN®, nurse practitioner at the University of California, San Francisco, told listeners during a conversation with Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS. Zitella explained the nursing and management considerations for febrile neutropenia and what to do if it transitions into sepsis. This episode is part of a series about oncologic emergencies; the previous episodes are also linked below. You can also earn free NCPD contact hours after listening to this episode by completing the evaluation linked below. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation. Episode Notes
To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From Today's Episode "We know that fever and neutropenia in combination needs to be treated immediately. This is a high-risk oncologic emergency. Our patients who have febrile neutropenia are at very high risk of having a severe infection or sepsis." Timestamp (TS) 03:44 "Patients with cancer are at an increased risk for infection because of the inherent immunosuppression of the cancer itself and also the treatment." TS 08:28 "There are some very, very basic things that patients can do [to decrease risk for infection]. The most important is good handwashing. I explain to patients that your skin is the best barrier against getting an infection. If there's no break in the skin, then infection cannot get in. So, if your hands get contaminated and you wash them before you touch your eyes or your mouth or your nose, then that is a good way to prevent infection." TS 11:42 "Even if a patient does everything perfect, most of the time when you're neutropenic, the infections that develop come from endogenous organisms. So, our body is colonized with probably 10 times as many microbes as human cells, and when the immune system is suppressed, it allows these organisms sometimes to cause infection. So, it's very important for patients to know that if they have signs of infection that they should let us know so that we can start immediate treatment to treat the infection." TS 14:01 "If patients are higher risk or they have any organ dysfunctions, or other symptoms—like they're unwell, nausea, vomiting, diarrhea, any symptoms like that—they should be admitted to the hospital, and we would initiate IV antibiotics." TS 17:37 "It's actually the nurse who's most often the person that first identifies sepsis in patients, so I think it's really important to trust your clinical judgement. When you look at a patient, it's really easy to tell when something is wrong. When they're starting to breathe too heavy or they're a little bit off and they're starting to get some altered mental status, or suddenly their heart rate is elevated for no reason even though they're just lying in bed. So, nurses are really positioned and are most often the ones who first pick up on these subtle signs." TS 27:17 | |||
| Episode 219: Use Acupuncture and Acupressure to Manage Cancer Symptoms and Side Effects | 05 Aug 2022 | 00:49:45 | |
"Using that view of looking at the whole person, we can provide some acupuncture or acupressure to help maybe reduce anxiety, to help them relax a little bit more, settle their thinking down a little bit, and get some improved sleep," ONS member Susan Yaguda, MSN, RN, RN manager in integrative oncology at the Atrium Health Levine Cancer Institute in Charlotte, NC, told Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, during a discussion on using acupuncture and acupressure to manage symptoms and side effects of cancer and cancer treatment. Yaguda also demonstrated example acupressure techniques that nurses can try at home and in their practice. You can earn free NCPD contact hours after listening to this episode by completing the evaluation linked below. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation. Episode Notes
To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From Today's Episode "When people have a disruption in their health—and it could be your emotional well-being, physical, or both—in traditional Chinese medicine, it is reflected in that the flow of qi has been disrupted. Acupuncture and acupressure address this by trying to open up and even out that flow, by either inserting tiny little needles called acupuncture needles, or by exerting gentle pressure—called acupressure—on specific acupoints." Timestamp (TS) 03:22 "What I really love about traditional Chinese medicine is it's very holistic. It's looking at the whole person, at systems working together, and it really meshes beautifully with what I think of as nursing practice, as nurses, that we step back and that we are looking at the whole person. And how maybe an imbalance in one area of one's life can definitely impact other areas as well." TS 05:27 "We know that patients who receive neurotoxic chemotherapies can develop painful neuropathy that can really be impactful on their quality of life. We have found, and the literature also supports, that if patients can come in and get some sessions of acupuncture, it can be really impactful on their neuropathy." TS 08:09 "Using that view of looking at the whole person, we can provide some acupuncture or acupressure to help maybe reduce anxiety, to help them relax a little bit more, settle their thinking down a little bit, and get some improved sleep, which as we all know is a very important part of health and well-being and definitely for our patients something that can better help them manage treatment moving forward." TS 10:56 "Integrative medicine looks at using complementary therapies in a very collaborative way with what we would consider to be more conventional medical treatment, so that it's coordinated and very intentionally meshed together to best suit the patients' needs at whatever point along the trajectory of their care." TS 12:58 "Some cancer centers do have an integrative medicine department, and oftentimes acupuncture is part of that." TS 15:56 "Not only could our care partners use some acupressure themselves to help with fatigue, anxiety, and their own sleep difficulties, but it gives them something that they can be easily trained to do to share with their loved one. And sometimes, it's so important for them to feel like they can contribute positively to their loved one's well-being in some sort of way. I always encourage, if possible, for a care partner to be involved in the process as well." TS 20:47 "Using battlefield acupuncture, or acupuncture and acupressure of any kind, is not a replacement for appropriate medical management of symptoms—whether it's pain, nausea, or anxiety, for example. Think about this as another tool in the toolbox to offer to our patients that has very few side effects. . . . It should never be considered a replacement for that type of care." TS 32:45 | |||
| Episode 218: Central Venous Catheters: Heparin Harms and Recommendations for Flushing | 29 Jul 2022 | 00:34:14 | |
"Saline is very benign and doesn't have any risk of harm for the patient. They're small doses, so we're not worried about sodium or anything. The risk of heparin is actually quite extensive," MiKaela Olsen, DNP, APRN-CNS, AOCNS®, FAAN, clinical program director in oncology at Johns Hopkins Hospital and Johns Hopkins Health System in Baltimore, MD, told Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, during a conversation about the latest evidence surrounding central venous catheter flushing solutions and techniques. You can earn free NCPD contact hours after listening to this episode by completing the evaluation linked below. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation. Episode Notes Check out these resources from today's episode:
To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From Today's Conversation "The way that you can eliminate heparin is by really focusing on education and teaching of patients and nurses and other staff that access central lines about how to do that." Timestamp (TS) 06:13 "One of the barriers right now I think is that a lot of the manufacturer guidelines are old, and they still recommend in their catheter guidelines to use heparin because they aren't up to date either." TS 07:50 "The risk of heparin is actually quite extensive. For instance, we know that heparin can cause heparin-induced thrombocytopenia, or HIT. Unfortunately, you don't always know that your patient is experiencing that, but I've had many, many patients over the years where, all of a sudden, their platelet count was low, and no one knew why. . . . We did testing for HIT and found out that it was the heparin flushes that were causing that." TS 09:04 "Normal saline is the most benign solution that can be used in catheters. There are studies showing benefit in some patient populations, and I know that some places have protocols using an antibiotic lock solution or a sodium citrate lock solution, but in general the most common type of flush solution for central lines as heparin begins to move out of favor is normal saline." TS 13:06 "We know that using a push-pause, pulsatile, or, I call it sometimes, turbulent flush, has been shown to promote the clearance of the catheter lumen and prevent occlusion. According to the Infusion Nursing Society guidelines. . . . we are instructed to stop and start every millimeter of flush. . . . That is really important because every time you stop and start, you cause turbulence in that catheter." TS 13:55 "When you study it, you find that patients or nurses are not actually flushing enough. If the patient's at home and you're using saline, then the catheter is usually flushed on a daily basis with pulsation when not in use. If the patient's giving themselves antibiotics or other medications through their catheter, they need to be taught how to do the saline flush after each of the medications." TS 17:47 | |||
| Episode 316: Pharmacology 101: Estrogen-Targeting Therapies | 14 Jun 2024 | 00:30:29 | |
"Estrogen plays a key role in promoting the proliferation of normal and breast cancer epithelium. So now we have gone from focusing just on the estrogen to also look at estrogen receptors on breast cancer cells and targeting that—and now even to a point of looking at the downstream effects of when the estrogen binds to estrogen receptor of those signaling pathways," Rowena "Moe" Schwartz, PharmD, BCOP, FHOPA, professor of pharmacy practice at James L. Winkle College of Pharmacy at the University of Cincinnati in Ohio, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about estrogen-targeting anticancer therapies. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to estrogen-targeting therapies. Episode Notes
To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast Club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "One of the kind of interesting things about [selective estrogen receptor degraders] is that these novel compounds also reduce the estrogen receptor alpha protein level. That becomes really important when we talk about elacestrant, because when there are mutations in the estrogen receptor protein, this is where this drug is actually indicated." TS 7:48 "Every time I talk about tamoxifen side effects, I just think about when I was early in my career and we used to talk at some support groups, and I would talk about tamoxifen having no side effects, because we really thought it had no side effects at that time. But we have learned since then that there are side effects because of its effect on other tissues. So one of the things that we have learned is that increased risk of endometrial cancer, and that is something really important for women to be aware of." TS 10:10 "It's important to monitor bone mineral density, prior to the initiation of therapy and then usually yearly afterward. And then again, stress some of those lifestyle management strategies: avoiding smoking, to avoid chronic alcohol use, vitamin D and calcium, regular weight-bearing exercises, as well as looking at things such as bisphosphonate therapy or denosumab for prevention of treatment-induced bone loss." TS 14:13 "I think there is this concept that hormone receptor–positive breast cancer is one disease. It is not. … Not only are there disease-specific aspects that we need to look at, there are patient-specific aspects that we need to look at: whether a patient is premenopausal or postmenopausal or male. Those are things that we need to consider. So I think the big misconception is that all of these drugs work the same way because all breast cancer is the same." TS 26:39
| |||
| Episode 217: Support Pregnant and Postpartum Patients During Cancer Diagnosis and Treatment | 22 Jul 2022 | 00:30:30 | |
"Caring for a pregnant patient with cancer is 100% a team approach," ONS member Chandley Silin, RN, FNP-BC, AOCNP®, nurse practitioner at the Stanford Cancer Center in Palo Alto, CA, told Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS. During this episode, Silin discussed the care implications for pregnant and postpartum patients with cancer throughout diagnosis and treatment and the importance of involving the interprofessional team and making appropriate referrals for support. You can earn free NCPD contact hours after listening to this episode by completing the evaluation linked below. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation. Episode Notes Check out these resources from today's episode:
To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. | |||
| Episode 216: Navigate Branded and Nonbranded Patient Education Industry Resources | 15 Jul 2022 | 00:30:04 | |
"What does the patient need to know? What are their knowledge gaps? What are they most in need of? Once you determine the areas you need to pinpoint, branded or nonbranded, then there's resources out there for you to use," Chelsea Backler, MSN, APRN, AGCNS-BC, AOCNS®, VA-BC, oncology clinical specialist at ONS, told Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS. Backler explained the differences between branded and nonbranded patient education resources, ways for oncology nurses to identify credible resources, and ONS's Seal of Approval Program for branded and nonbranded resources. You can earn free NCPD contact hours by completing the evaluation linked below. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation. Episode Notes Check out these resources from today's episode:
To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. | |||
| Episode 215: Navigate Updates in Oral Adherence to Cancer Therapies | 08 Jul 2022 | 00:36:36 | |
"The nurse is kind of the hub of a spoked wheel. You have your pharmacy and your provider all on the outside edge, but it's the nurse that's connecting all of these different support services together and being the main connection for the patient," ONS member Elizabeth Bettencourt, RN, MSN, OCN®, oral oncolytic nurse navigator at Palo Alto Medical Foundation in Sunnyvale, CA, and member of the Silicon Valley ONS Chapter, said. Bettencourt joined Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, for a discussion on how oncology nurses can support their patients in adherence to oral anticancer medications. The advertising messages in this episode are paid for by Breast Cancer Index. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Episode Notes
To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. | |||
| Episode 214: Oncologic Emergencies 101: Syndrome of Inappropriate Antidiuretic Hormone | 01 Jul 2022 | 00:23:35 | |
"Sometimes in our daily routine of taking care of patients, it's more about looking at the treatment side effects. But look at those wide array of symptoms that can present with an oncologic emergency. They will kind of sneak up on you, and as an oncology nurse, we all need to be educated about them," ONS member Diane Cope, PhD, APRN, BC, AOCNP®, director of nursing and oncology nurse practitioner at Florida Cancer Specialists and Research Institute in Fort Myers told Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS. During this episode, Cope explained the clinical manifestations associated with syndrome of inappropriate antidiuretic hormone (SIADH) and its medical and nursing interventions. The episode is part of a series about oncologic emergencies; the previous episodes are linked below. You can also earn free NCPD contact hours by completing the evaluation linked below. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation. Episode Notes Check out these resources from today's episode:
To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. | |||
| Episode 213: Meet the ONS Board of Directors: Brant, Burger, and Knoop | 24 Jun 2022 | 00:39:14 | |
What is it like to govern a professional association that serves more than 100,000 oncology nurses? ONS President Jeannine Brant, PhD, APRN-CNS, AOCN®, FAAN, and Directors-at-Large Val Burger, MA, MS, RN, OCN®, CPN, and Teresa Knoop, MSN, RN, AOCN®, reflect on their roles in the Board's executive committee, how a diverse Board supports a diverse membership, and how you can get involved in ONS leadership. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation. Episode Notes Check out these resources from today's episode:
To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. | |||
| Episode 212: When Cancer Care Gets Complex: Those Other Oncologic Emergencies | 17 Jun 2022 | 00:28:17 | |
When it comes to oncologic emergencies, early identification and intervention achieves the best outcomes, but some emergencies are harder to recognize. "Oncology nurses are often the first to pick up on important symptoms of serious complications," Laura Zitella, MS, RN, ACNP-BC, AOCN®, nurse practitioner at the University of California, San Francisco, said. Zitella joined Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to talk about recognizing less common complications seen in patients with cancer, such as adrenal crisis, pulmonary embolism, and malignant small bowel obstructions. She also presented on the topic at the 47th Annual ONS Congress® in Anaheim, CA, on April 27, 2022. The advertising messages in this episode are paid for by Breast Cancer Index. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Episode Notes Check out these resources from today's episode:
To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. | |||
| Episode 211: Apply the LGBTQIA+ Lived Experience to Your Patient Interactions | 10 Jun 2022 | 00:50:12 | |
"When we think about how oncology nurses can really be helpful in overcoming barriers to care, it comes back to what we do very well—which is getting to know our patients," David Rice, PhD, MSN, RN, NP, NEA-BC, chief nurse of research and development at the Greater Los Angeles VA Medical Center in California said during his conversation with Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS. David and Stephanie discussed the nursing considerations for LGBTQIA+ patients with cancer and how nurses can help overcome barriers and eliminate disparities during all stages of the cancer continuum. David facilitated a panel discussion on the topic at the 47th Annual ONS Congress® in Anaheim, CA, on April 29, 2022. You can also earn free NCPD contact hours by completing the evaluation linked below. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 1.00 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at myoutcomes.ons.org by June 10, 2024. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation. Episode Notes Check out these resources from today's episode:
To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. | |||
| Episode 210: Oncologic Emergencies 101: Spinal Cord Compression | 03 Jun 2022 | 00:47:28 | |
"We call it an oncologic emergency for a reason. Even though it's usually not life threatening, the longer we wait, the more debilitating and devastating the side effects will be," ONS member Jennifer Webster, MN, RN, AOCNS®, MPH, clinical nurse specialist at Northside Hospital in Atlanta, GA, and member of the Metro Atlanta ONS Chapter, said during her conversation with Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS. The nurses talked about the importance of early identification and intervention for malignant spinal cord compression and other nursing considerations for the oncologic emergency. This episode is a part of a series about oncologic emergencies; the previous episodes are linked below. You can also earn free NCPD contact hours by completing the evaluation linked below. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation. Episode Notes Check out these resources from today's episode:
To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. | |||
| Episode 209: Updates in Chemo PPE and Safe Handling | 27 May 2022 | 00:31:50 | |
Hazardous drugs are not just used in oncology, and their health risks for providers go far beyond reproductive toxicities. ONS member MiKaela Olsen, DNP, APRN-CNS, AOCNS®, FAAN, clinical program director in oncology at the Johns Hopkins Hospital and Johns Hopkins Health System in Baltimore, MD, talks with Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, about protecting yourself and your colleagues with the latest updates in hazardous drug safety, including a change for the process of doffing personal protective equipment (PPE). Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation. Episode Notes Check out these resources from today's episode:
To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. | |||
| Episode 208: How to Have Fertility Preservation Conversations With Your Patients | 20 May 2022 | 00:35:35 | |
Talking to patients about how their cancer and treatment affects their fertility can be challenging and complicated for oncology nurses, but we owe it to our patients to have those conversations. Megan Solinger, MHS, MA, OPN-CG, director of service and care delivery at the Ulman Foundation in Baltimore, MD, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to offer guidance, ideas, and advice that will prepare you to confidently approach those essential and ethical discussions. Megan presented the topic at the 47th Annual ONS Congress® in Anaheim, CA, on April 28, 2022. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at myoutcomes.ons.org by May 20, 2024. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation. Episode Notes Check out these resources from today's episode:
To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. | |||
| Episode 315: Processing Grief as an Oncology Nurse | 07 Jun 2024 | 00:55:10 | |
"I think the reality is that we as humans are having a human experience, some of which is incredible and some of which is terrible. And to deny ourselves the opportunity to feel any of those emotions would be to deny our own human experience. And so processing feelings, and I think the bigger ones in particular, like grief, especially in the work that we do, it's not only good to do, but it's part of just what it means to, I think, be a human," Ann Konkoly, MBA, MSN, APRN-CNM, chief executive officer of Authentic Koaching LLC and Kultivate Women's Health LLC, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about processing grief in a healthcare context. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to processing grief. Episode Notes
To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast Club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "Processing is just what we do with these big feelings or these small feelings that come up and how we work through them. And it really depends on the individual and what coping tools and mechanisms that they use. But usually for a lot of people, what we see is that when there is some sort of feeling—like grief—that comes along, one of the most important things that we can do is just to, number one, acknowledge that we are having some sort of a feeling and to then subsequently name it." TS 2:05 "The brain, usually the limbic system, is driven by these three main things that it wants you to do at all times: It wants you to seek pleasure—number one. Number two, it wants you to avoid pain. And number three, it wants you to conserve energy. … And so from an evolutionary standpoint, it totally makes sense that when faced with a feeling like grief, the limbic system drives us to say, 'Let's avoid all that pain, because that feels really heavy and hard, and it's going to take a lot of energy.' And so many of us from a purely, you know, as a human approach to things that cause pain, we usually turn away from them." TS 17:18 "For those of us out there who find we're somewhat ill equipped and our partners or our colleagues are saying, 'Boy, what's going on?' and we don't know, the next step is to say, 'Well, wait a minute. Who can help me kind of figure this out?' And I think whether it's therapy, whether it's a coach, whether it's a trusted mentor or colleague that you could have a very honest conversation with, whether it's your employee assistance program that provides you with some resources and support, there's no right or wrong way to go about it." TS 26:45 "We have good data to say just the act of naming a feeling can be so helpful, can decrease our symptoms of that emotion by about 50%, which is crazy. Just from naming it, just from acknowledging that there's a vibration there in your body and then naming it as like, 'Oh, that vibration, that feeling that I have in my body that equates to grief or shame or discouragement.'" TS 32:58 "Are you willing to train your brain to see it differently and to make it work for you, and to find a way that it can work for you, and that you can think differently and that you can change your mindset? Because if you can do that, if you can learn to allow your feelings to come up and process them like grief when they come, if you can observe what you do in certain situations and what you don't do—if you are willing to do that, you could go anywhere and do anything." TS 43:06 | |||
| Episode 207: Oncologic Emergencies 101: Malignant Pleural Effusion | 13 May 2022 | 00:28:44 | |
ONS member Roberta Kaplow, RN, PhD, CCRN, AOCNS®, clinical nurse specialist at Emory University Hospital in Atlanta, GA, and member of the Metro Atlanta ONS Chapter, talks with Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, about the latest nursing management and prevention strategies for malignant pleural effusion. This episode is a part of a series about oncologic emergencies; the previous episodes are linked in the episode notes. You can also earn free NCPD contact hours by completing the evaluation linked in the episode notes. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation. Episode Notes Check out these resources from today's episode:
The podcast conversations represent the guest's ideas and opinions and not necessarily those of ONS. Mention of specific products and opinions related to those products does not indicate endorsement by ONS. To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. | |||
| Episode 206: Graft-Versus-Host Disease: Biomarkers and Beyond | 06 May 2022 | 00:45:00 | |
"Biomarkers give us information not only to diagnose a patient, but also to see whether a patient is going to have GVHD in the near future, whether a patient is going to respond to the treatment we'll give, and what would be the overall outcome and survival." ONS member Nilesh Kalariya, PhD, AGPCNP-BC, AOCNP®, research nurse practitioner at MD Anderson Cancer Center in Houston, TX, talks with Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, about managing acute and chronic graft-versus-host disease (GVHD) and biomarkers for the condition. You can earn free NCPD contact hours by completing the evaluation linked in the episode notes. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation. Episode Notes Check out these resources from today's episode:
To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. | |||
| Episode 205: COVID-Driven Financial Toxicity and Cancer Care | 29 Apr 2022 | 00:36:48 | |
The inflating price tag of cancer care means that more patients are facing the difficult choice of paying for everyday needs or their cancer treatment. Matthew Banegas, PhD, MPH, MS, associate professor of radiation medicine and applied sciences at the University of California San Diego and a member of Moores Cancer Center's Cancer Control Program, talks with Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, about COVID-driven financial hardship and its implications for cancer care. Banegas presented about the topic at the 47th Annual ONS Congress in Anaheim, CA, on April 30, 2022; his session is linked in the episode notes. You can also earn free NCPD contact hours by completing the evaluation linked in the episode notes. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation. Episode Notes Check out these resources from today's episode:
To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. | |||
| Episode 204: How Radiation Is Used in Palliative Care | 22 Apr 2022 | 00:26:36 | |
"There's nothing more we can do." How often do patients with cancer hear those words? But ONS member Reanne Booker, RN, MN, a nurse practitioner at Foothills Medical Centre in Calgary, Alberta, Canada, believes differently: "I feel there's always more that we can do, even if cure is no longer possible." Booker talks with Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, about how radiation is used in palliative and end-of-life care and oncology nurses' role in helping patients and providers overcome misconceptions to increase access and use. She also presented on the topic at the 47th Annual ONS Congress® in Anaheim, CA, on April 30, 2022; her session is linked in the episode notes. You can also earn free NCPD contact hours by completing the evaluation linked in the episode notes.
Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation. Episode Notes Check out these resources from today's episode:
To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. | |||
| Episode 203: Oncologic Emergencies 101: Increased Intracranial Pressure | 15 Apr 2022 | 00:21:32 | |
Elevated intracranial pressure is a life-threatening cancer complication, but oncology nurses can take steps to prevent and recognize it in their patients. ONS member Mary Elizabeth Davis, DNP, RN, AOCNS®, clinical nurse specialist at Memorial Sloan Kettering Cancer Center in New York, NY, and member of the New York City ONS Chapter, talks with Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, about the latest nursing strategies for increased intracranial pressure, a situation that can occur with a brain tumor, abscess, infection, or other conditions that increases or obstructs cerebrospinal fluid or blood flow in the brain. This episode is part of a series about oncologic emergencies; the previous episodes are linked in the episode notes. You can also earn free NCPD contact hours by completing the evaluation linked in the episode notes. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at myoutcomes.ons.org by April 15, 2024. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation. Episode Notes Check out these resources from today's episode:
To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. | |||
| Episode 202: The Ethics of Oncology Data on Social Media | 08 Apr 2022 | 00:33:44 | |
Social media is an innovative study recruitment and intervention tool, but what are the ethical considerations surrounding its data? ONS member Lisa Carter-Harris, PhD, APRN, ANP-C, FAAN, associate attending behavioral scientist at Memorial Sloan-Kettering Cancer Center in New York, NY, talks with Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, about online health data, using social media for oncology clinical trials, and the ethical considerations surrounding all of it. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation. Episode Notes Check out these resources from today's episode:
To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. | |||
| Episode 201: Which Survivorship Care Model Is Right for Your Patient? | 01 Apr 2022 | 00:27:26 | |
Survivorship care models are a framework to build on and customize for each patient's needs, not a generic form for everyone. ONS member Michelle Mollica, PhD, MPH, RN, OCN®, senior advisor for the National Cancer Institute's Office of Cancer Survivorship in Bethesda, MD, talks with Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, about how nurses can tailor survivorship care models for each of their patients and a framework for building custom models. The advertising messages in this episode are brought to you by Biologics by McKesson. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Episode Notes Check out these resources from today's episode:
To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. | |||
| Episode 200: Meet the ONS Board of Directors: Houlihan, Ferguson, and Polovich | 25 Mar 2022 | 00:41:16 | |
What is it like to govern a professional association that serves more than 100,000 oncology nurses? ONS Board of Directors members Nancy Houlihan, MA, RN, AOCN®, Kristin Ferguson, DNP, RN, MSN, OCN®, and Marty Polovich, PhD, RN, AOCN®-Emeritus, reflect on their experiences of leading during a pandemic, how a diverse Board supports a diverse membership, and how you can get involved in ONS leadership. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation. Episode Notes Check out these resources from today's episode:
To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. | |||
| Episode 199: Oncologic Emergencies 101: Cardiac Tamponade | 18 Mar 2022 | 00:32:35 | |
Cardiac tamponade typically presents gradually over time, and it can happen multiple times throughout a patient's cancer care journey. Oncology nurses must stay cognizant of the warning signs and management approaches. ONS member Roberta Kaplow, RN, PhD, CCRN, AOCNS®, clinical nurse specialist at Emory University Hospital in Atlanta, GA, and member of the Metro Atlanta ONS Chapter, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss the latest nursing management and prevention strategies for cardiac tamponade. This episode is part of a series about oncologic emergencies; the previous ones are linked in the episode notes. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation. Episode Notes Check out these resources from today's episode:
To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. | |||
| Episode 198: Age-Friendly Cancer Care Considerations for Oncology Nurses | 11 Mar 2022 | 00:40:21 | |
Oncology nurses can dismantle ageism by providing person-centered care to all patients, no matter their age. ONS member Sarah H. Kagan PhD, RN, GCNS-BC, AOCN®, FGSA, FAAN, Lucy Walker Honorary Term Professor of Gerontological Nursing at the University of Pennsylvania and gerontology clinical nurse specialist in the Abramson Cancer Center at Pennsylvania Hospital, both in Philadelphia, and member of the Philadelphia ONS Chapter, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss nursing considerations for older patients with cancer. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation. Episode Notes Check out these resources from today's episode:
To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. | |||
| Episode 314: Plasma and Cryoprecipitate Administration: The Oncology Nurse's Role | 31 May 2024 | 00:18:07 | |
"Transfusion safety is really a registered nurse activity, and I just continue to reiterate the blessing of nursing assessment, getting those vitals before the transfusion, and then monitoring them closely and stopping the transfusion if they have a reaction, because that's really an assessment, and we can't delegate that to nonlicensed staff. And so that's really why we just celebrate that nurses have such a great role in transfusion safety," Renee LeBlanc, BSN, RN, manager of the infusion services office at Fred Hutchinson Cancer Center in Seattle, WA, told Lenise Taylor, MN, RN, AOCNS®, BMTCN®, oncology clinical specialist at ONS, during a conversation about administration of plasma and cryoprecipitate. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to plasma and cryoprecipitate administration. Episode Notes
To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast Club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "Plasma is indicated for massive transfusions and emergent reversal of warfarin therapy–related intracranial hemorrhage. Nurses may also see plasma ordered pre-op for multiple coagulation deficiencies or factor XI deficiency." TS 2:58 "Surgical centers performing procedures with large-volume blood loss would be a prime location for staff to be experts in transfusing plasma and cryo. Nurses caring for patients with cytokine release syndrome may be familiar with monitoring for hypofibrinogenemia. Cryoprecipitate in this setting may be given more prophylactically than for a patient who's actively bleeding or having a procedure." TS 6:48 "Plasma coagulation factors have a short half-life. Transfusing as close to the procedure will ensure the highest level of factor activity at the time of the procedure. Nurses can ensure best outcomes through care coordination and timing the transfusions as close to the procedure as possible. So we don't want to start transfusing plasma at midnight if the factors are going to be expiring and their procedure isn't until 9:00 in the morning." TS 10:40 "One of the questions that I get sometimes, especially with plasma, is, 'I don't have time to be at the bedside for 15 minutes for four units.' Remember that each unit is a different donor, and what they eat, what kind of antibodies they have, whether they were pregnant—it's all part of that experience. It's not the same plasma product given four different times or three different times. And so just really drawing nurses into the value of being at the bedside for that first 15 minutes of that final determination of acceptability and tolerance." TS 14:20
| |||
| Episode 197: Patient Learning Needs and Educational Assessments | 04 Mar 2022 | 00:37:45 | |
How do you know that your patients are prepared to receive your education? Do you have the right educational tools and resources for their level of learning and retention? Are you sure your patients understand what you've taught them? ONS member Beau Amaya, MSN, RN, OCN®, associate director of patient education and engagement at Memorial Sloan Kettering Cancer Center in New York, NY, and member of the New York City ONS Chapter, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss what nurses should consider when delivering patient education assessments for all phases of the treatment plan. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation. Episode Notes Check out these resources from today's episode:
To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. | |||
| Episode 196: Oncologic Emergencies 101: Bleeding and Thrombosis | 25 Feb 2022 | 00:30:45 | |
Early detection of bleeding directly affects survival rates for patients with cancer, but oncology nurses can improve outcomes by providing education and treatment for oncologic emergencies like thrombosis. ONS member Carrie Moore, MSN, OCN®, NE-BC, nurse manager at the Medical University of South Carolina in Charleston, and member of the South Carolina Low Country ONS Chapter, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss bleeding disorders and thrombosis and their current management and treatment strategies. This episode is part of a series about oncologic emergencies; the previous episodes are linked in the episode notes. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation. Episode Notes Check out these resources from today's episode:
To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. | |||
| Episode 195: Exercise's Effect on Patient and Provider Well-Being | 18 Feb 2022 | 00:34:41 | |
No matter what it looks like—from walking to yoga to completing a triathlon—movement's many physiologic benefits are well-rooted in evidence. ONS member Rachel Hirschey, PhD, RN, assistant professor in the School of Nursing at the University of North Carolina at Chapel Hill, associate member at Lineberger Comprehensive Cancer Center, and member of the North Carolina Triangle ONS Chapter, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss the physical and mental benefits of exercise, how it can help patients during and after cancer treatment, and strategies for clinicians to build their own sustainable exercise routines. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation. Episode Notes Check out these resources from today's episode:
To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. | |||
| Episode 194: Sex Is a Component of Patient-Centered Care | 11 Feb 2022 | 00:38:15 | |
Cancer disease and treatment can alter many aspects of sexual health, but patient concerns often remain unverbalized and unaddressed. Oncology nurses can push through awkwardness and provide resources to help patients rediscover intimacy during and after cancer. ONS member Marloe Esch, RN, BSN, OCN®, breast care nurse navigator at Froedtert and the Medical College of Wisconsin and member of the Southeastern Wisconsin ONS Chapter, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss how nurses can talk to their patients about sex and strategies for becoming more comfortable with those conversations. The advertising messages in this episode are paid for by Breast Cancer Index. Episode Notes Check out these resources from today's episode:
To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. | |||
| Episode 193: How Social Determinants of Health Affect Cardio-Oncology Survivorship | 04 Feb 2022 | 00:36:13 | |
Cardio-oncology care is complex, and social determinants of health may create life-threatening disparities for many patients. ONS member Lakeshia Cousin, PhD, APRN, AGPCNP-BC, assistant professor at the University of Florida College of Nursing in Gainesville and member of the Greater Tampa ONS Chapter, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss cardio-oncology survivorship, the influence of social determinants of health, and how nurses can promote equity in care to improve outcomes for their patients. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation. Episode Notes Check out these resources from today's episode:
To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. | |||
| Episode 192: Oncologic Emergencies 101: Hypercalcemia of Malignancy | 28 Jan 2022 | 00:33:53 | |
Hypercalcemia of malignancy (HCM) affects about 30% of all patients with cancer. Patients with breast cancer that has metastasized to bone and patients with squamous cell lung cancer together account for more than half of all HCM cases. ONS member Marcelle Kaplan, RN, MS, CNS, CBCN®–Emeritus, AOCN®–Emeritus, breast oncology clinical specialist and member of the Long Island/Queens ONS Chapter, and Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, discuss hypercalcemia of malignancy and its current treatment strategies. This episode is part of a series about oncologic emergencies; the other episodes are linked in the episode notes. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation. Episode Notes Check out these resources from today's episode:
To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. | |||
| Episode 191: Explore Orientation Opportunities for New-to-Practice Nurses | 21 Jan 2022 | 00:47:26 | |
For new-to-practice oncology nurses, orientation serves as a foundation to understanding the specialized needs of their unique patient population. Join ONS member Christina Klein, MSN, RN, CRNI, OCN®, education coordinator at Temple University Hospital in Philadelphia, PA, and member of the Bucks Montgomery Counties ONS Chapter, and Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, as they discuss orientating new-to-practice nurses as they begin their careers in oncology and educational resources to build on their existing knowledge. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 The NCPD activity for this episode has expired, but you can still earn NCPD through many other Oncology Nursing Podcast episodes. Find a full list of opportunities. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation. Episode Notes Check out these resources from today's episode:
To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. | |||
| Episode 190: The Environment, Cancer, and Nurses' Role in Advocating for Climate Change | 14 Jan 2022 | 00:39:01 | |
As a social determinant of health, a patient's environmental climate affects cancer risk, access to care, treatment adherence, cancer outcomes, and more. Join ONS member Milagros Elia, MA, APRN, ANP-BC, founder of M. Elia Nature-Based Healthcare Solutions, in Shrub Oak, NY, and Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, as they discuss the crucial need for a clinical focus on planetary health and an ONS grassroots approach to address and combat climate change and its impact on cancer care. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 The NCPD activity for this episode has expired, but you can still earn NCPD through many other Oncology Nursing Podcast episodes. Find a full list of opportunities. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation. Episode Notes Check out these resources from today's episode:
To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. | |||
| Episode 189: Consider the Ethical Implications of Germline Testing | 07 Jan 2022 | 00:44:33 | |
ONS member Suzanne Mahon, DNS, RN, AOCN®, AGN-BC, FAAN, a credentialed genetics professional and professor at Saint Louis University in Missouri and member of the St. Louis ONS Chapter, discusses the ethical dilemmas and implications that affect nurses and patients in germline testing, including informed consent, privacy concerns, and more. AstraZeneca sponsored this podcast episode, which is brought to you by ONS. Episode Notes Check out these resources from today's episode:
To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. | |||
| Episode 188: Oncology Nurse Entrepreneurs Are Innovating Beyond the Bedside | 31 Dec 2021 | 00:30:36 | |
ONS member Elaine DeMeyer, RN, MSN, AOCN®, BMTCN®, founder of beyond Oncology, which creates educational tools and resources for oncology professionals to help change their practice, and member of the Dallas ONS Chapter, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss how oncology nurses can become entrepreneurs and how you can support your colleagues who are developing niche businesses in the oncology arena. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation. Episode Notes Check out these resources from today's episode:
To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. | |||
| Episode 313: Cancer Symptom Management Basics: Other Pulmonary Complications | 24 May 2024 | 00:34:22 | |
"Of all the eight different pulmonary toxicities you and I have talked about over these two different podcasts, they're all very different etiologies and treatments. So, we went everywhere from infection and good stewardship with antibiotics to pulmonary GVHD to diffuse alveolar hemorrhage. And I think that's what's the hardest part for us as nurses. It's not just one thing that's causing it, and there's multiple different ways to treat these things," Beth Sandy, MSN, CRNP, thoracic medical oncology nurse practitioner at the Abramson Cancer Center at the University of Pennsylvania in Philadelphia told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about pulmonary toxicities in cancer treatment. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to pulmonary complications in people with cancer. Episode Notes
To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast Club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "[Intensity-modulated radiation therapy] is a type of radiation that can really take into account certain movements. And this is particularly important with the lungs, because we can't necessarily have patients hold their breath for a long period of time, so the chest rises and falls and the heart beats while you're trying to do radiation to the lungs. So with IMRT, they can simulate that, so that the beam is going to follow that specific movement in that patient. That's really helpful because then, hopefully, we're going to keep that radiation dose mostly on cancer tissue and not on healthy tissue. And thus, that should reduce the amount of radiation that's to the healthy tissue and hopefully reduce pneumonitis." TS 3:44 "Proton beam radiation is something that we've described in the past as radiation that will typically have an entrance dose but not an exit dose, so minimizing toxicity by hopefully around 50%. … If you're doing proton beam therapy, that radiation is designed to only have an entrance dose from either the back or the front or the side, whichever way they're going, but then hopefully stop on a dime at that tumor so that they're only really getting the entrance dose of that radiation. … So in turn, especially if you're doing that to the lungs, that should minimize dose of radiation to healthy lung tissue." TS 5:03 "If they're having a fever, low blood count, thick ugly mucus, this often, typically can be infection as well. And then get a chest x-ray because, a lot of times I've been saying for a lot of these things, we need a CT scan to see this. Actually, infection is probably best noted on a chest x-ray because this is something that will consolidate." TS 18:58 "[Tumors] may be directly invading a vessel. They may directly be invading the bronchus where there's a lot of capillaries or there's a lot of blood vessels that can break and then cause them to cough up blood. You can have tumors or prior treatment that then cause a bronchial fistula that then can cause bleeding. Patients with squamous cell carcinoma of the lung are much more likely to have hemoptysis and pulmonary hemorrhage than patients with adenocarcinoma, though it definitely can happen with adenocarcinoma as well." TS 22:00 "One of the best treatments for tumor-direct hemorrhage is radiation. This is where radiation can be very helpful for these patients. It's one of the first things that we do. We're going to go in with radiation, shrink that tumor really fast to get it away from those vessels, so patients stop bleeding." TS 27:17 | |||
| Episode 187: The Critical Need for Well-Being and Resiliency and How to Practice | 24 Dec 2021 | 00:42:22 | |
ONS member Patricia Jakel, RN, MN, AOCN®, retired clinical nurse specialist from UCLA Santa Monica Medical Center and member of the Greater Los Angeles ONS Chapter, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss the importance of well-being in the nursing profession and how it can reduce symptoms of burnout and improve resilience. Editor's note: If you consistently feel anxious, depressed, or overwhelmed, please seek the support of a mental health professional. The Heroes Health Initiative offers an array of coping and counseling services for healthcare workers and first responders. Remember, you are never alone. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 0.75 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at myoutcomes.ons.org by December 24, 2023. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation. Episode Notes Check out these resources from today's episode:
To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. | |||
| Episode 186: Certification Can Fuel Your Leadership Skills and Professional Growth | 17 Dec 2021 | 00:25:16 | |
Lori Williams, PhD, APRN, OCN®, AOCN®, president of the Oncology Nursing Certification Corporation (ONCC), joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss how oncology nurses can use certification to grow professionally and develop as a leader. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at myoutcomes.ons.org by December 17, 2023. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation. Episode Notes Check out these resources from today's episode:
To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. | |||
| Episode 185: Surgical Oncology: Where We've Come and Where We're Going | 10 Dec 2021 | 00:33:50 | |
ONS member Deena Dell, MSN, APRN, AOCN®, nursing professional development specialist in oncology at the Sarasota Memorial Hospital Brian D. Jellison Cancer Institute in Florida, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss the history of surgical oncology, how it has evolved in recent years, and what we can expect in the future of the specialty. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at myoutcomes.ons.org by December 10, 2023. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation. Episode Notes Check out these resources from today's episode:
To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. | |||